HSP90B2P and cancer: Extracellular HSPs and HSP-rich EVs can promote cancer progression by enhancing EMT, migration, invasion, heterogeneity, metastasis, CSC/CIC properties, and drug resistance in cancer cells and angiogenesis [113,114,115,116,117,118,119].